ABCL
Price
$5.11
Change
+$0.09 (+1.79%)
Updated
Jul 25 closing price
Capitalization
1.53B
11 days until earnings call
BEAM
Price
$21.72
Change
+$0.77 (+3.68%)
Updated
Jul 25 closing price
Capitalization
2.18B
16 days until earnings call
Interact to see
Advertisement

ABCL vs BEAM

Header iconABCL vs BEAM Comparison
Open Charts ABCL vs BEAMBanner chart's image
AbCellera Biologics
Price$5.11
Change+$0.09 (+1.79%)
Volume$5.19M
Capitalization1.53B
Beam Therapeutics
Price$21.72
Change+$0.77 (+3.68%)
Volume$1.62M
Capitalization2.18B
ABCL vs BEAM Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. BEAM commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and BEAM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ABCL: $5.11 vs. BEAM: $21.72)
Brand notoriety: ABCL and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 83% vs. BEAM: 79%
Market capitalization -- ABCL: $1.53B vs. BEAM: $2.18B
ABCL [@Biotechnology] is valued at $1.53B. BEAM’s [@Biotechnology] market capitalization is $2.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +14.32% price change this week, while BEAM (@Biotechnology) price change was +4.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 07, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.18B) has a higher market cap than ABCL($1.53B). ABCL YTD gains are higher at: 74.403 vs. BEAM (-12.419). ABCL has higher annual earnings (EBITDA): -211.2M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ABCL (605M). ABCL has less debt than BEAM: ABCL (67.8M) vs BEAM (158M). BEAM has higher revenues than ABCL: BEAM (63.6M) vs ABCL (23.1M).
ABCLBEAMABCL / BEAM
Capitalization1.53B2.18B70%
EBITDA-211.2M-399.03M53%
Gain YTD74.403-12.419-599%
P/E RatioN/AN/A-
Revenue23.1M63.6M36%
Total Cash605M1.22B50%
Total Debt67.8M158M43%
TECHNICAL ANALYSIS
Technical Analysis
ABCLBEAM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 28 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BREFX40.210.34
+0.85%
Baron Real Estate Retail
JHGEX13.060.05
+0.38%
JHancock Global Equity A
JEGRX17.880.01
+0.06%
Janus Henderson Global Sust Eq R
DNMDX29.19-0.01
-0.03%
Dunham Monthly Distribution N
PRAFX15.76-0.04
-0.25%
T. Rowe Price Real Assets

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.79%
CRSP - ABCL
59%
Loosely correlated
-1.97%
RXRX - ABCL
58%
Loosely correlated
+3.67%
ABSI - ABCL
54%
Loosely correlated
N/A
BEAM - ABCL
54%
Loosely correlated
+3.68%
NTLA - ABCL
53%
Loosely correlated
+6.38%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+3.68%
CRSP - BEAM
70%
Closely correlated
-1.97%
NTLA - BEAM
65%
Loosely correlated
+6.38%
RXRX - BEAM
63%
Loosely correlated
+3.67%
DNLI - BEAM
62%
Loosely correlated
-4.47%
SYRE - BEAM
58%
Loosely correlated
+1.08%
More